Mankind Pharma launches 'Limit White India' Campaign for BP Awareness

Mankind Pharma launches 'Limit White India' Campaign for BP Awareness

By, Admin 20 May 2024

Mankind Pharma launches 'Limit White India' Campaign to raise hypertension awareness

Overview

Mankind Pharma, the No.1 pharmaceutical company in the antihypertensive segment in India, as per MAT April’ 24 volume sale (Source: IQVIA) has launched a nationwide campaign on the occasion of World Hypertension Day called 'Limit White India'. This initiative aims to raise awareness about the dangers of excessive salt and sugar consumption which with other factors like sedentary lifestyle and obesity can be a major risk factor for hypertension. 

Hypertension in India

  • Studies have shown that 1 in 4 adults in India suffer from hypertension and 101 million people in India which is about 11.4% of the country's population, are living with diabetes. 
  • Diabetes and hypertension are often referred together as ""partners in crime"" due to their closely linked impact on global health.
  • It is common knowledge that these conditions not only coexist but exacerbate each other, creating a compounded risk of severe health issues such as cardiovascular diseases, stroke, and kidney failure.  
  • The 'Limit White India' campaign focuses on educating Indians to limit their intake of 'whites' like salt and sugar.
  • The campaign emphasises the need for gradual lifestyle changes to improve cardiovascular health. 
  • With the goal of driving a three-year awareness programme, Mankind Pharma aims to partner with healthcare professionals (HCPs) in the management of hypertension and diabetics across the country.

Words from CMO: Mankind 

  • "Hypertension is a silent killer, and Mankind Pharma is committed to tackling it head-on through the 'Limit White India' campaign."" said Dr Sanjay Koul, chief marketing officer, Mankind Pharma Ltd. 
  • "Excessive salt and sugar are significant contributors to uncontrolled blood pressure levels and blood sugar levels. Studies have shown Indians on average consume five times the WHO recommended quantity of sugar annually. By raising awareness and promoting lifestyle modifications, we aim to empower people to make informed choices for their well-being." 

Campaign Strategy

  • As part of the campaign, Mankind Pharma will engage cardiologists, endocrinologists, diabetologists, general practitioners, and the public through educational initiatives. 
  • These include conducting journal clubs, distributing 'Cardiac Cognizance' newsletters, radio awareness programmes with doctors, and blood pressure screening camps nationwide. 

Mankind Pharma

  • Mankind Pharma is one of the largest pharmaceutical company in India, which focuses on the domestic market with its Pan India presence. 
  • Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!